Free Trial
OTCMKTS:AXIM

AXIM Biotechnologies (AXIM) Stock Price, News & Analysis

AXIM Biotechnologies logo
$0.0034 +0.00 (+6.25%)
As of 03/28/2025 02:11 PM Eastern

About AXIM Biotechnologies Stock (OTCMKTS:AXIM)

Key Stats

Today's Range
$0.0031
$0.0034
50-Day Range
N/A
52-Week Range
$0.0013
$0.0190
Volume
114,770 shs
Average Volume
430,532 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

AXIM Biotechnologies, Inc. engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.

Remove Ads
Receive AXIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AXIM Biotechnologies and its competitors with MarketBeat's FREE daily newsletter.

AXIM Stock News Headlines

Trump’s Great Society
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
AXIM Biotechnologies, Inc. (AXIM)
AXIM Biotechnologies Inc AXIM
ADPT Adaptive Biotechnologies Corporation
See More Headlines

AXIM Stock Analysis - Frequently Asked Questions

AXIM Biotechnologies' stock was trading at $0.0019 at the beginning of 2025. Since then, AXIM shares have increased by 78.9% and is now trading at $0.0034.
View the best growth stocks for 2025 here
.

Shares of AXIM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that AXIM Biotechnologies investors own include Cronos Group (CRON), Canopy Growth (CGC), Tilray (TLRY), Charlotte's Web (CWBHF), Baidu (BIDU), Meta Platforms (META) and Micron Technology (MU).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:AXIM
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report

This page (OTCMKTS:AXIM) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners